During the past decade, Amarillo Heart Clinical Research Institute Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Amarillo Heart Clinical Research Institute Inc." #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "AtheroGenics" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Amarillo Heart Clinical Research Institute Inc." #1 collaborator was "Medtronic" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Alberta Innovation and Science" with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator and "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Amarillo Heart Clinical Research Institute Inc." are "Atherosclerotic Cardiovascular Disease" (3 trials), "Familial Hypercholesterolemia" (3 trials), "Coronary Artery Disease" (2 trials), "Myocardial Infarction" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Amarillo Heart Clinical Research Institute Inc." in a lesser frequency.

Most popular intervention types in "Amarillo Heart Clinical Research Institute Inc." are "Drug" (10 trials), "Device" (5 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Apixaban" (2 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials), "AGI-1067" (1 trials) and "ALN-PCSSC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Amarillo Heart Clinical Research Institute Inc." are 17 trials for "All" genders.

Currently, there are NaN active trials in "Amarillo Heart Clinical Research Institute Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Amarillo Heart Clinical Research Institute Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Amarillo Heart Clinical Research Institute Inc., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".